Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/…
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The S&P 500 fell but held above a key support level Thursday, as Nvidia shares dragged down AI stocks like AMD, ASML and Broadcom.
If any investor has stood the test of time, it’s Warren Buffett, and with good reason.
